LBA63Long-term survival in patients (pts) with advanced NSCLC in the KEYNOTE-010 study overall and in pts who completed two years of pembrolizumab (pembro)
Herbst, R S, Garon, E B, Kim, D-W, Chul Cho, B, Pérez Gracia, J L, Han, J-Y, Dubos Arvis, C, Majem, M, Forster, M, Monnet, I, Novello, S, Szalai, Z, Gubens, M A, Su, W-C, Ceresoli, G L, Samkari, A, JeVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy424.075
Date:
October, 2018
File:
PDF, 86 KB
english, 2018
File converter
More search results
More benefits 
